12.01.2017
- French drugmaker Ipsen has signed a definitive agreement to buy the global oncology assets of US-based Merrimack Pharmaceuticals in a deal worth potentially more than $1 billion...
29.10.2015
- The US Food and Drug Administration (FDA) has approved, with reservations, the new pancreatic cancer drug Onivyde manufactured by US drugmaker Merrimack for use in combination with...
